Subscribe: Market Wire - Chemicals
Preview: Market Wire - Chemicals

Marketwired - Chemicals

Marketwired - Chemicals

Last Build Date: Wed, 18 Oct 2017 18:09:05 EDT

Copyright: Copyright: (C) Marketwired

Agrium and PotashCorp Announce Receipt of Regulatory Approval in India

Wed, 18 Oct 2017 17:38:17 EDT

IEP Technologies Boosts Operational Efficiency and Enhances the Customer Experience with Coresystems

Tue, 17 Oct 2017 09:00:00 EDT

Benefits Delivered by Coresystems' Field Service Software Enable IEP Technologies to Accelerate Company Growth on a Global Scale

OmniMax International, Inc. announces new President, Americas

Mon, 16 Oct 2017 12:58:00 EDT

NORCROSS, GA--(Marketwired - October 16, 2017) - OmniMax International, Inc. announced today that, effective October 16, 2017, Harold Bevis will join the Company as President, Americas reporting to Richard C. Brown, Chief Executive Officer. Mr. Bevis previously served as President and CEO of Xerium Technologies from 2012 to 2017 and has broad industry expertise in building products, consumer products, aerospace, telecommunications, data communications, industrial systems, packaging, paper, and industrial textiles. He holds an MBA from Columbia Business School and a BS in Industrial Engineering from Iowa State University.

Superior Plus Announces Closing of Senior Unsecured Note Financing

Mon, 16 Oct 2017 09:08:05 EDT

TORONTO, ONTARIO--(Marketwired - Oct. 16, 2017) - Superior Plus Corp. (Superior) (TSX:SPB) is pleased to announce that its indirect wholly-owned subsidiary, Superior Plus LP (Superior LP), has closed on its previously announced private placement of CDN $150 million principal amount of 5.25% Senior Unsecured Notes (the Notes) due February 27, 2024 (the Offering). Superior LP intends to use the net proceeds of the Offering to fund the redemption of Superior's issued and outstanding 6.00% convertible unsecured subordinated debentures due June 30, 2019 (of which there is $97 million aggregate principal amount outstanding) (the 6.00% Debentures), and to initially repay drawn amounts under Superior LP's syndicated revolving credit facility, which can be redrawn for general corporate purposes. The redemption date in respect of the 6.00% Debentures is November 15, 2017.

Superior Plus Announces Acquisition of International Dioxcide, Inc. Expanding its Specialty Chemicals Business

Fri, 13 Oct 2017 09:20:00 EDT

TORONTO, ONTARIO--(Marketwired - Oct. 13, 2017) - Superior Plus Corp. ("Superior") (TSX:SPB) is pleased to announce it has entered into an agreement to acquire all of the issued and outstanding shares of International Dioxcide, Inc. ("IDI") from LANXESS Corporation. IDI provides sodium chlorite based solutions including small-scale chlorine dioxide generation technology for biocidal and oxidative applications in municipal drinking water disinfection, cooling tower treatment, oil and gas fracturing, stimulation and odour control, rendering, paper machine slimicide, process water, wastewater treatment and food processing. The purchase price will be funded by drawing on Superior's existing credit facility. The acquisition of IDI is anticipated to close during the fourth quarter of 2017, subject to the satisfaction of certain customary commercial conditions.

Superior Plus Announces 5.25% Senior Unsecured Note Financing and Redemption of 6.00% Convertible Unsecured Debentures due June 30, 2019

Thu, 12 Oct 2017 17:26:48 EDT

TORONTO, ONTARIO--(Marketwired - Oct. 12, 2017) - Superior Plus Corp. ("Superior") (TSX:SPB) is pleased to announce that its wholly-owned subsidiary Superior Plus LP ("Superior LP") has, pursuant to an underwriting agreement entered into today, agreed to issue and sell an additional CDN $150 million principal amount of its 5.25% Senior Unsecured Notes due February 27, 2024 (the "Notes") by way of private placement (the "Private Placement") under the indenture pursuant to which Superior LP previously issued CDN $250 million of Notes on February 27, 2017. The additional Notes will be issued at $1,015 per $1,000 principal amount and interest thereon will be payable semi-annually in arrears in equal instalments on February 27 and August 27 of each year with the first interest payment commencing on February 27, 2018. The additional Notes will form a single series with the previously issued Notes. The Private Placement is expected to close on or about October 16, 2017, subject to customary closing conditions.

Parkway Pantai Introduces Precision Medicine To Customise Treatment Plans For Cancer Patients

Wed, 11 Oct 2017 21:00:00 EDT

Patients to benefit from precision medicine and more accurate diagnostics in Parkway Pantai's hospitals across Asia; Acquired precision medicine platform through 55 per cent stake in Angsana Holdings